The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Akineton Retard 4 mg prolonged release tablets

Laboratorio Farmaceutico S.I.T.PA1253/002/001

Main Information

Trade NameAkineton Retard 4 mg prolonged release tablets
Active SubstancesBiperiden hydrochloride
Dosage FormProlonged-release tablet
Licence HolderLaboratorio Farmaceutico S.I.T.
Licence NumberPA1253/002/001

Group Information

ATC CodeN04AA Tertiary amines
N04AA02 biperiden


License statusAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe outer carton states that the tablets should not be chewed or crushed.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back